DNA, D(P-THIO)(C-A-C-C-C-A-C-C-C-A-A-G-A-A-C-A-G-G)
Advanced Unresectable Solid Tumors
Andes Biotechnologiesnucleic_acidPhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Advanced Unresectable Solid Tumors cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Plixorafenib Fore Biotherapeutics | Phase 1/2 | CCC |
Andes-1537 For Andes Biotechnologies | Phase 1 | CC |
CHEIROLIN FutureGen Biopharmaceutical (Beijing) Co., Ltd | Phase 1 | CC |
Same molecule, other indications
DNA, D(P-THIO)(C-A-C-C-C-A-C-C-C-A-A-G-A-A-C-A-G-G) is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →